Clinical Trial Update: Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the safety and acceptability of UC-781 rectal microbicide gel for HIV prevention and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UC-781 rectal microbicide gel (UC-781)

Snippet

Sponsor: University of California, Los Angeles | Conditions: HIV Infections | Phase 1 | Status: COMPLETED